Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001193125-26-212775
Filing Date
2026-05-07
Accepted
2026-05-07 20:28:23
Documents
14
Effectiveness Date
2026-05-07

Document Format Files

Seq Description Document Type Size
1 S-1MEF odtx-20260507.htm S-1MEF 104745
2 EX-5.1 odtx-ex5_1.htm EX-5.1 19843
3 EX-23.1 odtx-ex23_1.htm EX-23.1 3996
4 EX-FILING FEES odtx-exfiling_fees.htm   iXBRL EX-FILING FEES 25152
5 GRAPHIC img202443603_0.jpg GRAPHIC 4821
  Complete submission text file 0001193125-26-212775.txt   284374

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT odtx-exfiling_fees_htm.xml XML 4779
Mailing Address 51 SLEEPER STREET BOSTON MA 02210
Business Address 51 SLEEPER STREET BOSTON MA 02210 (212) 841-1000
Odyssey Therapeutics, Inc. (Filer) CIK: 0001882782 (see all company filings)

EIN.: 863384382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-295677 | Film No.: 26955639
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)